| 期 |
标题 |
文件 |
| 卷 30, 编号 9/10 (2023) |
Key aspects of cardiovascular damage in COVID-19 |
|
|
Salukhov V., Sagun B.
|
| 卷 31, 编号 1 (2024) |
Features of management of a patient with secondary progressive multiple sclerosis: a clinical case |
|
|
Belskaya G., Lukashevich I.
|
| 卷 32, 编号 4 (2025) |
Clinical features of arterial hypertension against the background of acute respiratory viral infection of various etiologies |
|
|
Mordyk A., Viktorova I., Antipova E., Streltsova V., Bagisheva N., Moiseeva M.
|
| 卷 31, 编号 9 (2024) |
Features of skin itching in HIV-infected patients with atopic dermatitis |
|
|
Evdokimov E., Svechnikova E., Ponezheva Z., Gorelova E.
|
| 卷 30, 编号 12 (2023) |
Features of compensation of carbohydrate metabolism in patients with type 2 diabetes mellitus hospitalized with coronavirus infection |
|
|
Markova T., Anchutina A., Stas M., Medzhidova M.
|
| 卷 31, 编号 6 (2024) |
Features of macro- and microvascular complications in patients with type 2 diabetes mellitus (observational case-control study) |
|
|
Bagriy A., Stefanenko A., Mikhailichenko E., Stefanenko E., Sabelnikova Y.
|
| 卷 30, 编号 3 (2023) |
Features of the pathogenesis of thyroid diseases in COVID-19 |
|
|
Maksim O., Romashevsky B., Demyanenco N.
|
| 卷 30, 编号 12 (2023) |
Features of liver damage in patients with thyrotoxicosis: clinical observation of hepatopathy against the background of taking thyreostatics |
|
|
Bulgakova S., Sharonova L., Dolgikh Y., Kosareva O., Treneva E., Kurmaev D.
|
| 卷 30, 编号 14 (2023) |
Features of the use of genetic engineering biological drugs in the treatment of patients with Crohn’s disease |
|
|
Fadeeva N., Knyazev O., Bordin D., Nikolskaya K., Chudnykh S., Dashkina N., Artykova G., Aliev E.
|
| 卷 31, 编号 9 (2024) |
Features of alteplase reperfusion therapy in the treatment of ischemic stroke and acute coronary syndrome |
|
|
Safiullina Z., Mezhonov E., Vyalkina Y., Shalaev S.
|
| 卷 31, 编号 5 (2024) |
Features of the course of dermatoses against the background of HIV infection |
|
|
Yusupovа L., Garaeva Z., Yunusovа E., Mavlyutova G.
|
| 卷 32, 编号 4 (2025) |
Features of the course and effectiveness of treatment of right ventricular myocardial infarction combined with inferior left ventricular myocardial infarction |
|
|
Kalinle H., Remizov O., Astakhova Z.
|
| 卷 31, 编号 8 (2024) |
Features of folliculogenesis in women with different body mass index: a cross-sectional comparative study |
|
|
Azizova K., Volkova A., Dora S., Zimina M., Ermolinskaya T.
|
| 卷 31, 编号 2 (2024) |
Osteoporosis and sarcopenia: association with nutritional status and physical performance in women with rheumatoid arthritis |
|
|
Dobrovolskaya O., Feklistov A., Kozyreva M., Demin N., Toroptsova N.
|
| 卷 30, 编号 1/2 (2023) |
Acute respiratory viral infections: possibilities of vitamin and mineral complexes in treatment, prevention and rehabilitation |
|
|
Trukhan D., Viktorova I., Ivanova D., Goloshubina V.
|
| 卷 32, 编号 1 (2025) |
Acute sinusitis (acute rhinosinusitis) in adults and children. Diagnostic and treatment algorithm |
|
|
Erofeeva S.
|
| 卷 31, 编号 3 (2024) |
Attitudes of medical university students to preconception preparation and their reproductive health |
|
|
Sevostyanova N., Maksimova Y., Novikov I., Marinkin I., Pozdnyakova N., Knyazeva I., Konovalenko Y.
|
| 卷 30, 编号 11 (2023) |
Delay of initiation of adjuvant chemotherapy in patients with early breast cancer: causes and consequences |
|
|
Dashyan G., Konstantinova V., Dzhelialov E., Akhmedov R., Semiletova Y., Zhurov A., Tyusenko A., Olchonova A., Pavlikova I., Belousov A.
|
| 卷 32, 编号 1 (2025) |
Assessment of the effect of minimum steady-state concentrations of angiotensin II receptor blockers on the dynamics of office blood pressure values in patients with newly diagnosed stage 1–2 arterial hypertension |
|
|
Rebrova E., Shikh E.
|
| 卷 31, 编号 2 (2024) |
Assessment of cognitive functions, physical activity, nutritional status in elderly and senile people with probable osteosarcopenia |
|
|
Bulgakova S., Sharonova L., Kurmaev D., Treneva E., Kosareva O., Dolgikh Y., Merzlova P.
|
| 卷 30, 编号 6/7 (2023) |
Evaluation of long-term results of treatment of patients with residual tumors (including those with minimal forms of ypT1abN0), with pathomorphological complete response (pCR) after neoadjuvant systemic therapy, with primary minimal breast cancer (pT1abN0M0) |
|
|
Pesotsky R., Semiglazov V., Krivorotko P., Tabagua T., Zernov K., Emelyanov A., Semiglazova T., Amirov N., Mortada V., Ulrikh D., Levchenko V., Rychagov K., Zirov K., Evseev V.
|
| 卷 31, 编号 6 (2024) |
Assessing the risk of recurrence of luminal HER2-negative breast cancer and the possibility of intensifying adjuvant hormonal therapy to reduce the risk of progression |
|
|
Gordeeva O.
|
| 卷 31, 编号 2 (2024) |
Assessment of risk factors for osteoporosis in patients with osteoarthritis |
|
|
Vaneeva A., Ivshina A., Filimonova O.
|
| 卷 32, 编号 1 (2025) |
Evaluation of the effectiveness of diet therapy enriched with insoluble dietary fibers in patients with hyperlipoproteinemia |
|
|
Derbeneva S., Shmeleva S., Kachalov S., Elgarova L.
|
| 卷 32, 编号 1 (2025) |
Evaluation of the effectiveness of advanced training courses for physicians |
|
|
Bontsevich R., Zavitkevich G., Maksimov M.
|
| 卷 32, 编号 3 (2025) |
Evaluation of the efficacy of pembrolizumab in patients with metastatic cervical cancer depending on the value of the neutrophil-lymphocyte index |
|
|
Orlova R., Gorkina Y.
|
| 卷 32, 编号 3 (2025) |
Pathogenetic aspects of menstrual and reproductive disorders in obese women |
|
|
Efendieva R., Dikke G., Abusueva Z., Shilova N.
|
| 卷 30, 编号 9/10 (2023) |
Pathogenetic mechanisms of the association of MMP-9 and TIMP-1 biomarkers with the severity of chronic obstructive pulmonary disease |
|
|
Vasilyeva L., Gosteva E., Suslova E., Elzhurkaeva L., Zolotareva М.
|
| 卷 30, 编号 8 (2023) |
Pathogenetic mechanisms of alopecia areata |
|
|
Kazhzhanova A., Yusupovа L.
|
| 卷 30, 编号 13 (2023) |
Pathology of the skin and mucous membranes in children with HIV infection |
|
|
Pozdnyakova O., Bychkov S., Nemchaninova O., Reshetnikova T.
|
| 卷 30, 编号 8 (2023) |
Nail pathology: clinical and laboratory aspects, issues of resistance to antimycotics |
|
|
Pozdnyakova O., Nemchaninova O., Sergeeva I., Chasnyk A., Reshetnikova T.
|
| 卷 32, 编号 5 (2025) |
Bite pathology in patients with signs of undifferentiated connective tissue dysplasia (UCTD). Possibilities of aesthetic correction of changes in the lower third of the face in patients with UCTD after orthodontic treatment |
|
|
Svechnikova E., Arutyunyan G., Artemyeva N., Morzhanaeva M., Terentyeva L., Devyatova A., Nelga I., Rzhevskaya E., Shcheglyuk D.
|
| 卷 30, 编号 13 (2023) |
Pathomorphological examination of tissues after the combined use of thread lifting and phototherapy |
|
|
Serov D.
|
| 卷 32, 编号 1 (2025) |
Patient-oriented choice of therapy for inflammatory bowel diseases: a clinical case |
|
|
Bakulin I., Zhuravleva M., Bereznitskaya M., Gutman E., Egorova T.
|
| 卷 30, 编号 6/7 (2023) |
Primary mediastinal B-cell lymphoma: evolution and prospects for first-line therapy. Literature review |
|
|
Kramynin L., Filatova L., Zyuzgin I., Motalkina M., Elkhova S., Dobrovolskaya E., Koviazin A., Semiglazova T.
|
| 卷 30, 编号 11 (2023) |
Primary resistance to anti-HER2 therapy: mechanisms of development and ways to overcome |
|
|
Dashyan G., Dzhelialov E., Konstantinova V., Gronskaya Y., Murskikh A., Akhmedov R., Tyusenko A., Olchonova A., Dyakonenko Z., Sereda O., Belousov A.
|
| 卷 31, 编号 2 (2024) |
Primary hyperaldosteronism: existing problems and possible solutions |
|
|
Ladygina D., Vastistova A., Shilenkova E., Platonova N., Beltsevich D., Fadeev V.
|
| 卷 30, 编号 9/10 (2023) |
Lipid peroxidation in the body of patients with tuberculosis |
|
|
Rumyantsev E., Krasnova N., Nikolaev V., Prokopiev E., Kirillina M., Sychev D.
|
| 卷 31, 编号 4 (2024) |
Personalization of the rehabilitation program for patients with degenerative dystrophic spine disease in the form of pain, muscle-tonic and tunnel syndromes |
|
|
Panteleev E., Matveev S.
|
| 卷 30, 编号 14 (2023) |
Personalized approach to the rehabilitation of patients with degenerative dystrophic disk disease and clinical manifestations in the form of poor posture and pain syndrome |
|
|
Panteleev E., Matveev S.
|
| 卷 30, 编号 1/2 (2023) |
A personalized approach to omalizumab therapy in patients with chronic spontaneous urticaria: case series |
|
|
Petukhova A.
|
| 卷 30, 编号 13 (2023) |
Personalized approach to the treatment of patients with skin psoriasis and inflammatory back pain, taking into account comorbid pathology |
|
|
Pereverzina N., Kruglova L.
|
| 卷 30, 编号 12 (2023) |
Promising directions for complex pharmacotherapy of thyroid diseases |
|
|
Aleshnikova K., Dzhavachyan M., Zvereva V., Dul V., Dzhavakhian D.
|
| 卷 30, 编号 4/5 (2023) |
Prospects for the use of metronidazole+miconazole in the treatment of mixed vaginal infections |
|
|
Kulikov I., Apolikhina I.
|
| 卷 30, 编号 8 (2023) |
Pyogenic granuloma of the nail bed, clinical cases and literature review |
|
|
Murakhovskaya E., Sysoeva T., Mertsalova I., Aleksandrova M.
|
| 卷 32, 编号 1 (2025) |
Pleiotropic effects of carbocysteine in patients with COPD |
|
|
Babak S., Gorbunova M., Malyavin A.
|
| 卷 30, 编号 4/5 (2023) |
Improving the efficiency and safety of iron deficiency treatment using micellar microencapsulation of iron (SUNACTIVE® Fe) |
|
|
Shikh E., Emelyanova L.
|
| 卷 31, 编号 4 (2024) |
Approaches to the diagnosis and treatment of patients with stage III–IV non-small cell lung cancer in Russia. Preliminary results of a retrospective multicenter non-interventional observational study |
|
|
Reutova E., Laktionov K.
|
| 卷 31, 编号 8 (2024) |
Blood lipid profile in patients with obesity and type 2 diabetes mellitus and without type 2 diabetes mellitus before and after bariatric surgery |
|
|
Mozgunova V., Volkova A., Semikova G., Khalimov Y., Vasilevsky D., Balandov S., Anisimova K.
|
| 卷 30, 编号 1/2 (2023) |
Endothelial dysfunction indicators in children with hemolytic-uremic syndrome |
|
|
Makarova T., Davlieva L., Melnikova Y., Khusnutdinova D.
|
| 卷 30, 编号 1/2 (2023) |
TSLP gene polymorphic rs1837253 variants in occupational asthma |
|
|
Babanov S., Baykova A., Lavrentieva N., Strizhakov L., Lotkov V.
|
| 卷 31, 编号 1 (2024) |
Polypills in the fight against cardiovascular diseases: a modern review of effectiveness |
|
|
Leonova M.
|
| 卷 30, 编号 14 (2023) |
Upper gastrointestinal involvement in Crohn’s disease |
|
|
Uspensky Y., Gulunov Z.
|
| 卷 32, 编号 2 (2025) |
Adrenal masses in Gardner syndrome: difficulties in diagnosis and treatment (case report and brief review) |
|
|
Drachuk E., Gaidaichuk K., Ivaschenko K., Pachuashvili N., Urusova L., Godzenko M., Tarbaeva N., Pigarova E., Dzeranova L., Platonova N.
|
| 卷 31, 编号 9 (2024) |
Spleen damage in HIV infection, diagnostic and treatment issues |
|
|
Sundukov A., Puchkov S., Faller A., Svechnikova E.
|
| 卷 30, 编号 4/5 (2023) |
Postoperative ileus in gynecological practice: a simple, effective and safe solution to the problem |
|
|
Trukhan D., Degovtsov E., Degovtsova E.
|
| 卷 31, 编号 1 (2024) |
Guideline on acute cystitis (uncomplicated urinary tract infection) (ICD-10 code N30.0) for general practitioners |
|
|
Sinyakova L., Kosova I., Loran O., Barsegian V.
|
| 卷 30, 编号 8 (2023) |
Postcovid alopecia: from the study of pathogenesis to the choice of therapy |
|
|
Nikolaeva A., Bitkina O., Kosheleva I., Presnyakova M., Kontorshchikova K., Dmitrieva A., Peretyagin P., Tsyganova A.
|
| 卷 30, 编号 12 (2023) |
Consumption of oral anticoagulants in hospitals of the Russian Federation: analysis of the dynamics of procurement data |
|
|
Matveev A., Glagoleva S., Sychev D.
|
| 卷 32, 编号 3 (2025) |
Predictors of infection with resistant pathogens and the possibility of risk stratification in surgical obstetrics |
|
|
Korobkov N., Kakhiani E., Olina A., Dudnichenko T., Tolibova G., Sigua B.
|
| 卷 32, 编号 1 (2025) |
Predictors of nocturnal hypoxemia in stable COPD patients |
|
|
Babak S., Gorbunova M., Malyavin A.
|
| 卷 32, 编号 3 (2025) |
Pre-induction of labor: analysis of the mifepristone effectiveness in primiparous and multiparous women |
|
|
Pestrikova T., Barbotko D., Leshcheva D.
|
| 卷 30, 编号 1/2 (2023) |
Delayed-release drugs for the treatment of knee osteoarthritis – drugs of choice in a comorbid patient |
|
|
Andriyashkina D., Klimenko A., Demidova N., Kondrashov A., Anischenko M.
|
| 卷 31, 编号 6 (2024) |
Adherence to adjuvant hormonal therapy for luminal HER2-negative breast cancer: results of a patient survey |
|
|
Gordeeva O., Bokova S.
|
| 卷 31, 编号 8 (2024) |
Adherence to modern technologies of glycemic management in diabetic patients |
|
|
Chernikova N., Prokhorova K., Gancho I.
|
| 卷 31, 编号 3 (2024) |
The use of D-mannose in the prevention of recurrent urinary tract infections |
|
|
Teterina T., Tarnaeva L., Apolikhina I.
|
| 卷 31, 编号 1 (2024) |
The use of angiotensin II type 1 receptor antagonists in the treatment of chronic heart failure against the background of the renin-angiotensin-aldosterone system genetic polymorphisms |
|
|
Izmozherova N., Grenaderova M., Shambatov M., Popov A., Kudryavtseva E., Bortnik A., Vishneva K., Shamilov M.
|
| 卷 30, 编号 12 (2023) |
The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus |
|
|
Petrov V., Shatalova O., Klykova M., Stetsky N.
|
| 卷 32, 编号 4 (2025) |
Application of therapeutic exercises and robot-assisted therapy after stroke |
|
|
Eremin M., Shmeleva S., Tuzov I., Trofimenko Y., Bakulina E., Morozova E., Karpinsky A.
|
| 卷 31, 编号 4 (2024) |
The use of natural mineral water “Donat” for functional constipation and constipation in comorbid patients |
|
|
Trukhan D., Rozhkova M.
|
| 卷 31, 编号 6 (2024) |
The use of propafenone in the treatment of atrial fibrillation |
|
|
Syrov A.
|
| 卷 31, 编号 2 (2024) |
Pegvisomant in the treatment of acromegaly |
|
|
Rebrova D., Vorokhobina N.
|
| 卷 30, 编号 9/10 (2023) |
Principles of diet therapy for pediatric patients with acute intestinal infections |
|
|
Gorbunov S., Kovtun T.
|
| 卷 30, 编号 9/10 (2023) |
Acquired androgen deficiency as a predictor of metabolic syndrome and ischemic stroke in men |
|
|
Koltsova E., Petrova E., Kudryavceva A.
|
| 卷 31, 编号 9 (2024) |
Priority areas of acute sinusitis therapy |
|
|
Gurov A., Yushkina M., Muzhichkova A.
|
| 卷 31, 编号 2 (2024) |
Reasons and ways to reduce the severity of the acute phase reaction in the treatment of osteoporosis with intravenous bisphosphonates (literature review) |
|
|
Belova K., Ershova O., Nazarova A., Matyakubova Z.
|
| 卷 32, 编号 3 (2025) |
Probiotics in the practice of a gynecologist: a new chapter in the treatment of vaginal infections and dysbiosis |
|
|
Apolikhina I., Tarnaeva L.
|
| 卷 31, 编号 4 (2024) |
Probiotics in the treatment of irritable bowel syndrome: a tribute to tradition or a necessity? |
|
|
Gaus O., Livzan M., Lisovsky M.
|
| 卷 30, 编号 9/10 (2023) |
Problems of managing patients with COPD in the post-pandemic waves of COVID-19 |
|
|
Belotserkovskaya Y., Romanovskikh A., Smirnov I.
|
| 卷 30, 编号 9/10 (2023) |
Problems of medicine provision in dermatovenerology at the present stage |
|
|
Martynov A., Vlasova A.
|
| 卷 30, 编号 1/2 (2023) |
Problems of neuroprotective therapy of acute cerebrovascular accident |
|
|
Klimov L., Akarachkova E., Lebedeva D.
|
| 卷 30, 编号 3 (2023) |
Problems of pancreas transplantation and the role of bioengineered materials in long-term survival and functioning of islet cells |
|
|
Bulgakova S., Sharonova L., Dolgikh Y., Kosareva O., Treneva E., Kurmaev D.
|
| 卷 31, 编号 7 (2024) |
Chemotherapy in patients with advanced gastrointestinal tumors and end-stage chronic kidney disease. Brief literature review and clinical case reports |
|
|
Abdulaeva R., Gavrilova D., Makiev G., Obarevich E., Gromova E., Besova N., Tryakin A., Guzhavin D.
|
| 卷 32, 编号 3 (2025) |
Prognostic value of low HER2 expression in patients with early breast cancer |
|
|
Bekkeldiyeva N., Semiglazov V., Kudaibergenova A., Emelyanov A., Nikolaev K., Mortada V., Zernov K., Raimzhanov C., Tabagua T., Pesotsky R., Bondarchuk Y., Amirov N., Enaldieva D., Ulrikh D., Levchenko V., Krivorotko P.
|
| 卷 31, 编号 5 (2024) |
Parry-Romberg progressive facial hemiatrophy |
|
|
Garaeva Z., Yusupovа L., Mavlyutova G., Yunusovа E., Mavleeva A.
|
| 卷 31, 编号 6 (2024) |
Pelvic floor prolapse and connective tissue dysplasia: literature review, general possibilities of conservative correction |
|
|
Shershakova E., Apolikhina I., Buturlina A., Saidova A.
|
| 卷 30, 编号 3 (2023) |
A prospective cohort study of the association of MTNR1B, MTNR1A polymorphic gene variants with metabolic and sleep disorders during glucocorticoid therapy in patients with multiple sclerosis |
|
|
Brovkina S., Dzherieva I., Volkova N., Goncharova Z., Reshetnikov I.
|
| 卷 30, 编号 11 (2023) |
Prospective randomized phase III trial comparing FOLFIRINOX and mFOLFOX6 as first-line treatment for patients with disseminated gastric cancer: interim assessment of tolerability and toxicity |
|
|
Gavrilova D., Besova N., Obarevich E., Makiev G., Tryakin A., Stilidi I.
|
| 卷 30, 编号 9/10 (2023) |
Countermeasures to the use of narcotic analgesics as pharmacological doping by athletes |
|
|
Gaisina E., Basova E., Frolova M., Gоskov A.
|
| 卷 32, 编号 1 (2025) |
Regional tuberculosis control service: formation and prospects for increasing its efficiency (on the example of preventing the spread of tuberculosis in the Kursk region) |
|
|
Kolomiets V., Gavrilyuk E., Balobanova N., Valiev R., Alymenko M., Lipatov V., Sidnyaev V., Gerbig N., Kamyshnikova E., Veryaskina A.
|
| 卷 31, 编号 1 (2024) |
VR-IC (virtual reality in intensive care) clinical trial protocol: a program for the prevention of delirium and complications of long-term ICU patients using virtual reality |
|
|
Shiroky R., Zakaryaeva A., Murtazalieva D., Zolotov M., Yakovlev M., Kvitivadze N., Parfenov I., Fomin V.
|
| 卷 32, 编号 4 (2025) |
Professional burnout of medical workers in specialized departments |
|
|
Babanov S., Strizhakov L., Lysova M., Babanov A., Kuvshinova N.
|
| 卷 32, 编号 5 (2025) |
Psoriasis of special localizations. Experience with the use of the interleukin-17A inhibitor netakimab for the treatment of psoriasis of special localizations |
|
|
Svechnikova E., Zhufina S., Rzhevskaya E., Gladko V., Izmaylova I.
|
| 卷 32, 编号 4 (2025) |
Steady-state plasma bromdihydrochlorophenylbenzodiazepine concentrations in men with alcohol withdrawal syndrome: impact on safety |
|
|
Ivashchenko D., Zimina P., Illarionova M., Kuzmin I., Miroshnichenko I., Sychev D.
|
| 卷 32, 编号 2 (2025) |
Development of primary hyperparathyroidism due to ectopic parathyroid adenoma in the upper mediastinum: a clinical case in practice |
|
|
Morozova G., Boeva V., Ivaschenko E., Popova A.
|
| 卷 31, 编号 9 (2024) |
Development of an algorithm for predicting the risk of cough development during enalapril therapy in patients with arterial hypertension |
|
|
Sychev I., Denisenko N., Lapshtaeva A., Kachanova A., Abdullaev S., Kupriyanov Y., Goncharova L., Mirzaev K., Sychev D.
|
| 卷 31, 编号 7 (2024) |
Nasopharyngeal cancer. ESMO 2024 news |
|
|
Golubev P., Bolotina L., Kuzmina E., Pokataev I., Golubeva A., Kyanzhin E., Kuzmin V., Galkin V.
|
| 卷 31, 编号 6 (2024) |
Early administration of intravenous iron at cesarean section |
|
|
Ryazanova O., Pylaeva N., Shadenkov V., Petrova K., Makishev S.
|
| 卷 31, 编号 9 (2024) |
Prevalence and risk factors for the development of dermatophytosis. experience in treating the “transformed variant” of microsporia with systemic and local terbinafine |
|
|
Svechnikova E., Zhufina S.
|
| 卷 30, 编号 8 (2023) |
The prevalence of phakomatoses in Western Siberia |
|
|
Maximova Y., Chupyrko N., Vasilyeva M., Garny V., Maximov V., Svechnikova E.
|
| 301 - 400 的 576 信息 |
<< < 1 2 3 4 5 6 > >> |
